cytarabine has been researched along with Sensitivity and Specificity in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 17 (41.46) | 18.2507 |
| 2000's | 17 (41.46) | 29.6817 |
| 2010's | 6 (14.63) | 24.3611 |
| 2020's | 1 (2.44) | 2.80 |
| Authors | Studies |
|---|---|
| Mattila, P; Räbinä, J; Renkonen, R | 1 |
| Berda-Haddad, Y; Ciccolini, J; Costello, R; Donnette, M; Fanciullino, R; Farnault, L; Giocanti, M; Hau, LTT; Lacarelle, B; Ouafik, L; Solas, C; Venton, G | 1 |
| Acramel, A; Chouquet, T; Goldwirt, L; Jouenne, F; Mourah, S; Plé, A; Sauvageon, H | 1 |
| Aimiuwu, J; Blum, W; Chan, KK; Chen, P; Grever, MR; Klisovic, R; Liu, S; Liu, Z; Marcucci, G; Pang, J; Xie, Z | 1 |
| Keating, A; Wang, XH; Williams, BA | 1 |
| Hendriks, G; Hilhorst, MJ; Sillén, H; van de Merbel, NC; van Hout, MW | 1 |
| Luger, SM | 1 |
| Abdelhamid, E; Berthon, C; Castaigne, S; Gardin, C; Gruson, B; Helevaut, N; Nibourel, O; Preudhomme, C; Renneville, A; Rousselot, P; Soua, Z | 1 |
| Levasseur, SD; White, VA; Wittenberg, LA | 1 |
| de la Fuente, J; Goldman, JM; Hatjiharissi, E; Meletis, J; Rahemtulla, A; Szydlo, R; Terpos, E; Viniou, N; Yataganas, X | 1 |
| Cornely, O; Neurohr, K; Reiser, M; Schinköthe, T; Staib, P; Staltmeier, E | 1 |
| Abd El-Hady, D; Abo El-Maali, N; Andrisano, V; Gotti, R | 1 |
| Ueda, T; Yamauchi, T | 1 |
| Andreeff, M; Carew, JS; Huang, P; Keating, MJ; McQueen, TJ; Pelicano, H; Plunkett, W | 1 |
| Marcucci, G | 1 |
| Ala-Kopsala, M; Hartikainen, J; Jantunen, E; Kuittinen, T; Mussalo, H; Nousiainen, T; Vanninen, E; Vuolteenaho, O | 1 |
| Nishi, R; Ueda, T; Yamauchi, T | 1 |
| Becton, DL; Buck, S; Chang, M; Raimondi, SC; Ravindranath, Y; Savaşan, S; Weinstein, H | 1 |
| Humphreys, P; Johnston, DL; Keene, DL; Pound, CM; Udjus, K | 1 |
| Duncan, CJ; Hsieh, Y; Li, F | 1 |
| Attilio, G; Cristina, L; Edoardo, DN; Giuseppe, L; Loredana, G; Vincenzo, L | 1 |
| Cabanillas, F; Cortes, JE; Kurzrock, R; Seymour, JF; Talpaz, M | 1 |
| Creutzig, U; Harbott, J; Löffler, H; Ludwig, WD; Riehm, H; Ritter, J; Schellong, G; Sperling, C; Zimmermann, M | 1 |
| Haas, OA; Kapiotis, S; Knöbl, P; Korninger, L; Kyrle, PA; Laczika, K; Mitterbauer, G; Oehler, L; Pont, J; Schwarzinger, I | 1 |
| Hänseler, E; Rentsch, KM; Schott, H; Schwendener, RA | 1 |
| Nakamura, T; Ueda, T; Yamauchi, T | 1 |
| Schwartz, HE; Ulfelder, KJ | 1 |
| Appelbaum, FR; Banker, DE; Groudine, M; Norwood, T | 1 |
| Dibenedetto, SP; Lo Nigro, L; Mayer, SP; Rovera, G; Schilirò, G | 1 |
| Appelbaum, FR; Banker, DE; Groudine, M; Norwood, T; Willman, CL | 1 |
| Ehninger, G; Illmer, T; Neubauer, A; Nowak, R; Oelschlägel, U; Renner, U; Schaich, M; Subat, S; Ziegs, B | 1 |
| Algara, P; Díaz, MA; Madero, L; Martínez, P; Tutor-Ureta, O | 1 |
| Dewald, GW; Silver, RT; Wyatt, WA | 1 |
| Cole, KJ; Grover, PL; Martin, FL; Orme, MH; Phillips, DH; Venitt, S | 1 |
| Pallis, M; Russell, NH; Syan, J | 1 |
| Bousquet, B; Deschamps, F; Dombret, H; Gourmel, B; Houzé, P | 1 |
| Fukushima, T; Goto, N; Imamura, S; Iwasaki, H; Kawai, Y; Kishi, S; Masada, M; Tsutani, H; Ueda, T; Urasaki, Y; Yamauchi, T; Yoshida, A | 1 |
| Ansoborlo, S; Babin-Boilletot, A; Baruchel, A; Pacquement, H; Patte, C; Plouvier, E; Sakiroglu, C | 1 |
| Mancini, WR | 1 |
| Gandhi, V; Plunkett, W | 1 |
| Chan, TC; Cook, JR; Coppoc, GL; DeNicola, DB; Richardson, RC; Samuels, ML; Scott-Moncrieff, JC | 1 |
1 review(s) available for cytarabine and Sensitivity and Specificity
| Article | Year |
|---|---|
Is a nadir bone marrow required and, if so, what to do with residual disease?
Topics: Anthracyclines; Antineoplastic Agents; Biopsy; Bone Marrow; Cytarabine; Cytogenetics; Humans; Leukemia, Myeloid, Acute; Neoplasm, Residual; Practice Guidelines as Topic; Prognosis; Remission Induction; Retrospective Studies; Sensitivity and Specificity; Survival Rate; United States | 2011 |
5 trial(s) available for cytarabine and Sensitivity and Specificity
| Article | Year |
|---|---|
HPLC-MS/MS method for the determination of cytarabine in human plasma.
Topics: Antimetabolites, Antineoplastic; Chromatography, High Pressure Liquid; Chromatography, Liquid; Cytarabine; Drug Stability; Humans; Sensitivity and Specificity; Tandem Mass Spectrometry | 2011 |
Prediction of individual response to chemotherapy in patients with acute myeloid leukaemia using the chemosensitivity index Ci.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Screening Assays, Antitumor; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Survival Analysis; Thioguanine; Treatment Outcome; Tumor Cells, Cultured | 2005 |
Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).
Topics: Adolescent; Adult; Amenorrhea; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Female; Follicle Stimulating Hormone; Glycoproteins; Hodgkin Disease; Humans; Infertility, Female; Inhibins; Luteinizing Hormone; Mechlorethamine; Ovarian Follicle; Ovary; Predictive Value of Tests; Prednisolone; Prednisone; Primary Ovarian Insufficiency; Procarbazine; Sensitivity and Specificity; Survivors; Testicular Hormones; Time Factors; Triptorelin Pamoate; Ultrasonography; Vinblastine; Vincristine | 2007 |
Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87.
Topics: Acute Disease; Adolescent; Antibodies, Monoclonal; Antigens, CD; Antigens, Neoplasm; Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Child, Preschool; Chromosome Aberrations; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Humans; Immunophenotyping; Infant; Leukemia, Myeloid; Neoplastic Stem Cells; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Sensitivity and Specificity; Treatment Outcome | 1995 |
Rapid achievement of PML-RAR alpha polymerase chain reaction (PCR)-negativity by combined treatment with all-trans-retinoic acid and chemotherapy in acute promyelocytic leukemia: a pilot study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Chromosomes, Human, Pair 15; Cytarabine; Daunorubicin; Humans; Leukemia, Promyelocytic, Acute; Molecular Sequence Data; Pilot Projects; Polymerase Chain Reaction; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Sensitivity and Specificity; Tretinoin | 1994 |
35 other study(ies) available for cytarabine and Sensitivity and Specificity
| Article | Year |
|---|---|
Two time-resolved fluorometric high-throughput assays for quantitation of GDP-L-fucose.
Topics: Chemistry, Clinical; Dose-Response Relationship, Drug; Fucose; Fucosyltransferases; Guanosine Diphosphate Fucose; Guanosine Diphosphate Mannose; Lectins; Saccharomyces cerevisiae; Sensitivity and Specificity; Spectrometry, Fluorescence; Time Factors; Transformation, Genetic | 2000 |
Simultaneous determination of cytosine arabinoside and its metabolite uracil arabinoside in human plasma by LC-MS/MS: Application to pharmacokinetics-pharmacogenetics pilot study in AML patients.
Topics: Antimetabolites, Antineoplastic; Arabinofuranosyluracil; Chromatography, High Pressure Liquid; Cytarabine; Drug Monitoring; Humans; Leukemia, Myeloid, Acute; Linear Models; Pilot Projects; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2019 |
Development and validation of a liquid chromatography tandem mass spectrometry quantification method for 14 cytotoxic drugs in environmental samples.
Topics: Antineoplastic Agents; Chromatography, High Pressure Liquid; Cyclophosphamide; Cytarabine; Deoxycytidine; Doxorubicin; Environmental Pollutants; Gemcitabine; Occupational Exposure; Paclitaxel; Sensitivity and Specificity; Tandem Mass Spectrometry | 2020 |
A LC-MS/MS method for the analysis of intracellular nucleoside triphosphate levels.
Topics: Antimetabolites, Antineoplastic; Bone Marrow Cells; Cell Line, Tumor; Chromatography, Liquid; Cytarabine; Humans; Leukemia; Leukemia, Myeloid, Acute; Linear Models; Nucleotides; Oligodeoxyribonucleotides; Sensitivity and Specificity; Tandem Mass Spectrometry | 2009 |
Clonogenic assays measure leukemia stem cell killing not detectable by chromium release and flow cytometric cytotoxicity assays.
Topics: ADP-ribosyl Cyclase 1; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cell Culture Techniques; Cell Line, Tumor; Cell Separation; Chromium Isotopes; Cytarabine; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Daunorubicin; Flow Cytometry; Humans; Killer Cells, Natural; Leukemia; Neoplastic Stem Cells; Sensitivity and Specificity; Tumor Stem Cell Assay | 2010 |
Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cytarabine; Feasibility Studies; Female; fms-Like Tyrosine Kinase 3; Gene Duplication; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Nuclear Proteins; Nucleophosmin; Prognosis; Real-Time Polymerase Chain Reaction; Remission Induction; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Tandem Repeat Sequences; WT1 Proteins | 2012 |
Vitreoretinal lymphoma: a 20-year review of incidence, clinical and cytologic features, treatment, and outcomes.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; British Columbia; Combined Modality Therapy; Cytarabine; Eye Neoplasms; False Positive Reactions; Female; Humans; Incidence; Lymphoma; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Predictive Value of Tests; Radiotherapy; Retinal Neoplasms; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Vitrectomy; Vitreous Body | 2013 |
Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
Topics: Acid Phosphatase; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Biomarkers; Biomarkers, Tumor; Bone Neoplasms; C-Reactive Protein; Cytarabine; Dexamethasone; Diphosphonates; Female; Glycoproteins; Humans; Interleukin-6; Isoenzymes; Male; Middle Aged; Multiple Myeloma; Osteocalcin; Osteoclasts; Osteogenesis; Osteoprotegerin; Pamidronate; Paraproteins; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Reference Values; Sensitivity and Specificity; Tartrate-Resistant Acid Phosphatase; Vincristine | 2003 |
Simultaneous separation and determination of Tarabine PFS and Adriblastine using micellar electrokinetic chromatography and high performance liquid chromatography. Application to some biological fluids.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Chromatography, High Pressure Liquid; Chromatography, Micellar Electrokinetic Capillary; Cytarabine; Doxorubicin; Humans; Molecular Structure; Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Urine | 2005 |
A sensitive new method for clinically monitoring cytarabine concentrations at the DNA level in leukemic cells.
Topics: Aged; Antimetabolites, Antineoplastic; Cytarabine; DNA, Neoplasm; Drug Monitoring; Female; HL-60 Cells; Humans; Leukemia; Male; Middle Aged; Sensitivity and Specificity; Tumor Cells, Cultured | 2005 |
Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-C.
Topics: Acute Disease; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Benzoquinones; Cytarabine; DNA; Drug Administration Schedule; Drug Antagonism; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; G1 Phase; HeLa Cells; HSP90 Heat-Shock Proteins; Humans; Jurkat Cells; Lactams, Macrocyclic; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Oxides; Sensitivity and Specificity; Structure-Activity Relationship; Tumor Cells, Cultured | 2006 |
Core binding factor acute myeloid leukemia.
Topics: Acute Disease; Core Binding Factors; Cytarabine; Dose-Response Relationship, Drug; Humans; Leukemia, Myeloid; Neoplasm, Residual; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Treatment Outcome | 2006 |
Cardiac effects within 3 months of BEAC high-dose therapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Atrial Natriuretic Factor; Biomarkers; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Gated Blood-Pool Imaging; Heart; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Postoperative Period; Prospective Studies; Protein Precursors; Sensitivity and Specificity; Stroke Volume; Systole; Transplantation, Autologous; Ventricular Dysfunction, Left | 2006 |
A new, simple method for quantifying gemcitabine triphosphate in cancer cells using isocratic high-performance liquid chromatography.
Topics: Antimetabolites, Antineoplastic; Arabinofuranosylcytosine Triphosphate; Chromatography, High Pressure Liquid; Cytarabine; Deoxycytidine; Gemcitabine; HL-60 Cells; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Sensitivity and Specificity | 2006 |
CD36 (thrombospondin receptor) expression in childhood acute megakaryoblastic leukemia: in vitro drug sensitivity and outcome.
Topics: Adolescent; Adult; Biomarkers, Tumor; CD36 Antigens; Cell Membrane; Child; Child, Preschool; Cytarabine; Daunorubicin; Down Syndrome; Gene Expression Regulation, Neoplastic; Humans; Immunophenotyping; Infant; Infant, Newborn; Leukemia, Megakaryoblastic, Acute; Sensitivity and Specificity; Treatment Outcome | 2006 |
Acute encephalopathy and cerebral vasospasm after multiagent chemotherapy including PEG-asparaginase and intrathecal cytarabine for the treatment of acute lymphoblastic leukemia.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain; Brain Diseases; Burkitt Lymphoma; Child; Cytarabine; Female; Follow-Up Studies; Humans; Injections, Spinal; Magnetic Resonance Angiography; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sensitivity and Specificity; Treatment Outcome; Vasospasm, Intracranial | 2007 |
Supercritical fluid chromatography and high-performance liquid chromatography/tandem mass spectrometric methods for the determination of cytarabine in mouse plasma.
Topics: Animals; Chromatography, High Pressure Liquid; Chromatography, Supercritical Fluid; Cytarabine; Mice; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2007 |
Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Interleukin-10; Life Tables; Lymphoma, Large B-Cell, Diffuse; Male; Mesna; Methotrexate; Methylprednisolone Hemisuccinate; Middle Aged; Mitoxantrone; Neoplasm Proteins; Prognosis; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Survival Analysis; Treatment Outcome; Vincristine | 1995 |
Sensitive high-performance liquid chromatographic method for the determination of N4-hexadecyl- and N4-octadecyl-1-beta-D-arabinofuranosylcytosine in plasma and erythrocytes.
Topics: Animals; Antineoplastic Agents; Butanols; Chromatography, High Pressure Liquid; Cytarabine; Erythrocytes; Female; Humans; Mice; Mice, Inbred ICR; Reproducibility of Results; Sensitivity and Specificity; Sonication; Urea | 1995 |
A new sensitive method for determination of intracellular 1-beta-D-arabinofuranosylcytosine 5'-triphosphate content in human materials in vivo.
Topics: Alkaline Phosphatase; Arabinofuranosylcytosine Triphosphate; Blast Crisis; Cell Line; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Cytarabine; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Radioimmunoassay; Sensitivity and Specificity; Tumor Cells, Cultured | 1996 |
Analysis of bases, nucleosides, and (oligo)nucleotides by capillary electrophoresis.
Topics: Capillary Action; Cytarabine; DNA; Drug Monitoring; Electrophoresis; Humans; Leukemia; Lymphocytes; Nucleosides; Nucleotides; Oligonucleotides; Purines; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 1996 |
Measurement of spontaneous and therapeutic agent-induced apoptosis with BCL-2 protein expression in acute myeloid leukemia.
Topics: Acute Disease; Antineoplastic Agents; Apoptosis; Bone Marrow; Cell Separation; Cytarabine; Daunorubicin; Disease Progression; Flow Cytometry; Gene Expression Regulation, Leukemic; Genes, p53; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid; Neoplasm Proteins; Neoplastic Stem Cells; Proto-Oncogene Proteins c-bcl-2; Reproducibility of Results; Sensitivity and Specificity; Tumor Cells, Cultured | 1997 |
Detectable molecular residual disease at the beginning of maintenance therapy indicates poor outcome in children with T-cell acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; Blotting, Southern; Bone Marrow; Child; Child, Preschool; Cohort Studies; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; DNA, Neoplasm; Evaluation Studies as Topic; Female; Fluorometry; Gene Rearrangement, delta-Chain T-Cell Antigen Receptor; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Humans; Immunophenotyping; Infant; Italy; Leucovorin; Leukemia-Lymphoma, Adult T-Cell; Male; Mercaptopurine; Methotrexate; Neoplasm, Residual; Neoplastic Stem Cells; Nucleic Acid Hybridization; Polymerase Chain Reaction; Prednisone; Prognosis; Prospective Studies; Receptors, Antigen, T-Cell, gamma-delta; Remission Induction; Sensitivity and Specificity; Treatment Outcome; Vincristine | 1997 |
Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents.
Topics: Acute Disease; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Cell Cycle; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Flow Cytometry; Genes, p53; Humans; Immunophenotyping; Karyotyping; Leukemia, Myeloid; Mutation; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-bcl-2; Reproducibility of Results; Sensitivity and Specificity | 1998 |
A new PCR MIMIC strategy to quantify low mdr1 mRNA levels in drug resistant cell lines and AML blast samples.
Topics: Acute Disease; Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Chromosome Banding; Cytarabine; Daunorubicin; DNA, Complementary; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Leukemic; Genes, MDR; Humans; K562 Cells; Leukemia, Myeloid; Middle Aged; Mitoxantrone; Neoplasm Proteins; Neoplastic Stem Cells; Oligonucleotide Probes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Sensitivity and Specificity; Tumor Cells, Cultured | 1999 |
[The presence of minimal residual disease during induction therapy is a reliable factor for the prognosis of recurrence in children with standard-risk B-cell precursor acute lymphoblastic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; DNA Primers; Genes, T-Cell Receptor delta; Humans; Mercaptopurine; Methotrexate; Molecular Sequence Data; Neoplasm, Residual; Polymerase Chain Reaction; Prednisone; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Vincristine | 1999 |
Atypical BCR and ABL D-FISH patterns in chronic myeloid leukemia and their possible role in therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 9; Cytarabine; Genes, abl; Humans; In Situ Hybridization, Fluorescence; Interferon alpha-2; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Oncogene Proteins; Philadelphia Chromosome; Predictive Value of Tests; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcr; Recombinant Proteins; Sensitivity and Specificity; Translocation, Genetic | 1999 |
The DNA repair inhibitors hydroxyurea and cytosine arabinoside enhance the sensitivity of the alkaline single-cell gel electrophoresis ('comet') assay in metabolically-competent MCL-5 cells.
Topics: Amines; Benzene; Bleomycin; Cell Line; Cell Survival; Chlorides; Chromates; Chromium Compounds; Cisplatin; Cytarabine; Diethylstilbestrol; DNA; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Electrophoresis, Agar Gel; Heterocyclic Compounds; Hexachlorocyclohexane; Humans; Hydroxyurea; Methylnitronitrosoguanidine; Mutagenicity Tests; Nitro Compounds; Nucleic Acid Synthesis Inhibitors; Polycyclic Aromatic Hydrocarbons; Radiation, Ionizing; Reproducibility of Results; Sensitivity and Specificity; Sodium Compounds; Sucrose | 1999 |
Flow cytometric chemosensitivity analysis of blasts from patients with acute myeloblastic leukemia and myelodysplastic syndromes: the use of 7AAD with antibodies to CD45 or CD34.
Topics: Antibodies; Antigens, CD34; Cell Count; Cytarabine; Dactinomycin; Flow Cytometry; Fluorescent Dyes; Humans; Leukemia, Myeloid, Acute; Leukocyte Common Antigens; Light; Myelodysplastic Syndromes; Scattering, Radiation; Sensitivity and Specificity; Stem Cells; Tumor Cells, Cultured | 1999 |
Micellar electrokinetic capillary chromatography quantification of cytosine arabinoside and its metabolite, uracil arabinoside, in human serum.
Topics: Antimetabolites, Antineoplastic; Arabinofuranosyluracil; Chromatography, Micellar Electrokinetic Capillary; Cytarabine; Humans; Leukemia, Myeloid; Osmolar Concentration; Reproducibility of Results; Sensitivity and Specificity; Temperature | 2001 |
Close correlation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate, an intracellular active metabolite, to the therapeutic efficacy of N(4)-behenoyl-1-beta-D-arabinofuranosylcytosine therapy for acute myelogenous leukemia.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Arabinofuranosylcytosine Triphosphate; Area Under Curve; Biotransformation; Cytarabine; Female; Humans; Infusions, Intravenous; Intracellular Fluid; Leukemia, Myeloid; Male; Middle Aged; Neoplastic Stem Cells; Prodrugs; Remission Induction; Sensitivity and Specificity; Treatment Outcome | 2001 |
Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d'Oncologie Pédiatrique LMB89 protocol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; France; Humans; Hydrocortisone; Leucovorin; Lymphoma, B-Cell; Male; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Rate; Treatment Outcome; Tumor Lysis Syndrome; Urate Oxidase; Vincristine | 2002 |
The role of deoxycytidine-metabolizing enzymes in the cytotoxicity induced by 3'-amino-2',3'-dideoxycytidine and cytosine arabinoside.
Topics: Animals; Antineoplastic Agents; Cell Count; Cell Division; Cytarabine; Cytidine Deaminase; Deoxycytidine; HeLa Cells; Humans; Leukemia L1210; Mice; Nucleoside Deaminases; Sensitivity and Specificity; Tumor Cells, Cultured; Zalcitabine | 1992 |
Cell cycle-specific metabolism of arabinosyl nucleosides in K562 human leukemia cells.
Topics: Antineoplastic Agents; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Cell Cycle; Cytarabine; Deoxycytidine Kinase; Drug Synergism; G1 Phase; G2 Phase; Humans; Intracellular Fluid; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Metaphase; Nucleotides; S Phase; Sensitivity and Specificity; Tumor Cells, Cultured; Vidarabine | 1992 |
Plasma and cerebrospinal fluid pharmacokinetics of cytosine arabinoside in dogs.
Topics: Animals; Blood-Brain Barrier; Chromatography, High Pressure Liquid; Cytarabine; Dogs; Half-Life; Infusions, Intravenous; Injections, Intravenous; Male; Sensitivity and Specificity; Time Factors | 1991 |